This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: eradication. This study aimed to assess the therapeutic outcomes and adverse events of vonoprazan-amoxicillin dual therapy compared to quadruple therapy. METHODS: eradication and adverse events. CONCLUSION: -infected patients, suggesting its potential for clinical application and promotion.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: